CKB FLEX - Trademark Details
Status: 641 - Non-Final Action - Mailed
Image for trademark with serial number 88955795
Serial Number
88955795
Word Mark
CKB FLEX
Status
641 - Non-Final Action - Mailed
Status Date
2021-10-12
Filing Date
2020-06-09
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Christina M. Licursi
Law Office Assigned Location Code
M40
Employee Name
KERTGATE, AMY L
Statements
Goods and Services
medical research services; biomedical research services; scientific research in the field of genomics and cancer; providing online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online, non-downloadable software used for the sequencing and analyses of genomic data; providing online, non-downloadable software used to integrate and create data models; providing online computer databases of genomic sequences for scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for analyzing and visualizing genomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biochemistry; providing online, non-downloadable software for use in clinical trial data management and electronic health records; information technology consulting services relating to the collection, review, analysis and reporting of clinical trial and drug development information and electronic health records; development of scientific research and technology for purposes of evaluating health status disease diagnosis; providing medical and scientific research information in the field of genomics, cancer, and clinical trials
Goods and Services
medical research services; biomedical research services; scientific research in the field of genomics and cancer; providing online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online, non-downloadable software used for the sequencing and analyses of genomic data; providing online, non-downloadable software used to integrate and create data models; providing online computer databases of genomic sequences for scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for analyzing and visualizing genomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biochemistry; providing online, non-downloadable software for use in clinical trial data management and electronic health records; information technology consulting services relating to the collection, review, analysis and reporting of clinical trial and drug development information and electronic health records; development of scientific research and technology for purposes of evaluating health status disease diagnosis; providing medical and scientific research information in the field of genomics, cancer, and clinical trials
Pseudo Mark
CLINICAL KNOWLEDGE BASE FLEX
Section 2(f) Limitation Statement
CKB has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-02-12
Primary Code
042
First Use Anywhere Date
2018-10-00
First Use In Commerce Date
2018-10-00
Current Trademark Owners
Party Name
The Jackson Laboratory
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Christina M. Licursi
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2020-07-02NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-07-24TEAS VOLUNTARY AMENDMENT RECEIVED
2020-08-08ASSIGNED TO EXAMINER
2020-08-10ASSIGNED TO LIE
2020-08-12NON-FINAL ACTION WRITTEN
2020-08-12NON-FINAL ACTION E-MAILED
2020-08-12NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-02-11TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-02-11CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-02-12TEAS/EMAIL CORRESPONDENCE ENTERED
2021-03-08NON-FINAL ACTION WRITTEN
2021-03-08NON-FINAL ACTION E-MAILED
2021-03-08NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-09-08TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-09-08CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-09-09TEAS/EMAIL CORRESPONDENCE ENTERED
2021-10-12NON-FINAL ACTION WRITTEN
2021-10-12NON-FINAL ACTION E-MAILED
2021-10-12NOTIFICATION OF NON-FINAL ACTION E-MAILED